{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "13",
                "@year": "2023",
                "@timestamp": "2023-07-13T20:21:09.000009-04:00",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2019",
                "@month": "09"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Britannia Pharmaceuticals Ltd."},
                {"xocs:funding-agency-matched-string": "Chula Research Scholar"},
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn Academic Advancement Fund into Its 2nd Century Project of Chulalongkorn University",
                    "xocs:funding-id": [
                        {"$": "2300042200"},
                        {"$": "GCE 6100930004-1"}
                    ]
                },
                {"xocs:funding-agency-matched-string": "Grant for International Research Integration"},
                {
                    "xocs:funding-agency-matched-string": "International Research Network",
                    "xocs:funding-id": "IRN59W0005"
                },
                {"xocs:funding-agency-matched-string": "Medtronics, Novartis"},
                {
                    "xocs:funding-agency-matched-string": "Rachadapiseksomphot Endowment Fund",
                    "xocs:funding-id": "CU-GRS-60-09-30-04"
                },
                {"xocs:funding-agency-matched-string": "Teva-Lundbeck"},
                {"xocs:funding-agency-matched-string": "Thailand Research Fund, Chulalongkorn"},
                {"xocs:funding-agency-matched-string": "The Neurological Society of Thailand"},
                {
                    "xocs:funding-agency-matched-string": "Abbott",
                    "xocs:funding-agency": "Abbott Laboratories",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100001316",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "GlaxoSmithKline",
                    "xocs:funding-agency-acronym": "GSK",
                    "xocs:funding-agency": "GlaxoSmithKline",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004330",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis",
                    "xocs:funding-agency": "Novartis",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004336",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Roche",
                    "xocs:funding-agency": "Roche",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004337",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Newton Fund",
                    "xocs:funding-agency": "Newton Fund",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100010897",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Chulalongkorn University",
                    "xocs:funding-agency-acronym": "CU",
                    "xocs:funding-agency": "Chulalongkorn University",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "National Science and Technology Development Agency",
                    "xocs:funding-agency-acronym": "NSTDA",
                    "xocs:funding-agency": "National Science and Technology Development Agency",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004192",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Thailand Research Fund",
                    "xocs:funding-agency-acronym": "TRF",
                    "xocs:funding-agency": "Thailand Research Fund",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004396",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                },
                {
                    "xocs:funding-agency-matched-string": "Ipsen Pharmaceuticals",
                    "xocs:funding-agency": "Ipsen",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100014382",
                    "xocs:funding-agency-country": "http://sws.geonames.org/3017382/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-05-30T02:14:44.965Z",
            "xocs:funding-text": [
                {"$": "Address correspondence and reprint requests to Professor Roongroj Bhidayasiri, MD, FRCP, Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders, Chulalongkorn University Hospital, 1873 Rama 4 Rd, Pathumwan, Bangkok 10330, Thailand; E\u2010mail: rbh@chulapd.org Conflicts of interest and source of funding: R. B. has received consultancy and/ or honoraria/lecture fees from Abbott, Boehringer-Ingelheim, Britannia Pharmaceuticals, GlaxoSmithKline, Ipsen Pharmaceuticals, Novartis, and Teva-Lundbeck, and has received research funding from the Newton Fund, the UK Government, Thailand Research Fund, Crown Property Bureau, Chulalongkorn University, and the National Science and Technology Development Agency."},
                {"$": "Editorial assistance in the preparation of this article was provided by Dr Karen Wolstencroft, supported by Britannia Pharmaceuticals Ltd."},
                {"$": "This study was supported by the International Research Network grant (IRN59W0005) of the Thailand Research Fund, Chulalongkorn Academic Advancement Fund into Its 2nd Century Project of Chulalongkorn University (2300042200), Center of Excellence grant of Chulalongkorn University (GCE 6100930004-1), and Grant for International Research Integration, Chula Research Scholar, Rachadapiseksomphot Endowment Fund (CU-GRS-60-09-30-04)."},
                {"$": "O. P. has received research support from Chulalongkorn University, Thailand Research Fund, The Neurological Society of Thailand, and Cerebos Award, and speaking honoraria from Medtronics, Novartis, Roche, and Boehringer-Ingelheim."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "1873 Rama 4 Rd",
                            "postal-code": "10330",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Pathumwan, Bangkok",
                            "organization": [
                                {"$": "Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders"},
                                {"$": "Chulalongkorn University Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60022183",
                                "@dptid": "104136245"
                            },
                            "ce:source-text": "Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders Chulalongkorn University Hospital 1873 Rama 4 Rd, Pathumwan, Bangkok 10330, Thailand",
                            "@dptid": "104136245"
                        },
                        "author": [
                            {
                                "ce:given-name": "Roongroj",
                                "preferred-name": {
                                    "ce:given-name": "Roongroj",
                                    "ce:initials": "R.",
                                    "ce:surname": "Bhidayasiri",
                                    "ce:indexed-name": "Bhidayasiri R."
                                },
                                "@seq": "1",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD, FRCP",
                                "ce:surname": "Bhidayasiri",
                                "@auid": "55882458500",
                                "ce:indexed-name": "Bhidayasiri R."
                            },
                            {
                                "ce:given-name": "Onanong",
                                "preferred-name": {
                                    "ce:given-name": "Onanong",
                                    "ce:initials": "O.",
                                    "ce:surname": "Phokaewvarangkul",
                                    "ce:indexed-name": "Phokaewvarangkul O."
                                },
                                "@seq": "2",
                                "ce:initials": "O.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD, PhD",
                                "ce:surname": "Phokaewvarangkul",
                                "@auid": "57204085936",
                                "ce:indexed-name": "Phokaewvarangkul O."
                            },
                            {
                                "ce:given-name": "Kamolwan",
                                "preferred-name": {
                                    "ce:given-name": "Kamolwan",
                                    "ce:initials": "K.",
                                    "ce:surname": "Boonpang",
                                    "ce:indexed-name": "Boonpang K."
                                },
                                "@seq": "3",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "RN",
                                "ce:surname": "Boonpang",
                                "@auid": "56660632600",
                                "ce:indexed-name": "Boonpang K."
                            },
                            {
                                "ce:given-name": "Thanatat",
                                "preferred-name": {
                                    "ce:given-name": "Thanatat",
                                    "ce:initials": "T.",
                                    "ce:surname": "Boonmongkol",
                                    "ce:indexed-name": "Boonmongkol T."
                                },
                                "@seq": "4",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Boonmongkol",
                                "@auid": "57211136260",
                                "ce:indexed-name": "Boonmongkol T."
                            },
                            {
                                "ce:given-name": "Yuwadee",
                                "preferred-name": {
                                    "ce:given-name": "Yuwadee",
                                    "ce:initials": "Y.",
                                    "ce:surname": "Thongchuem",
                                    "ce:indexed-name": "Thongchuem Y."
                                },
                                "@seq": "5",
                                "ce:initials": "Y.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Thongchuem",
                                "@auid": "57211142161",
                                "ce:indexed-name": "Thongchuem Y."
                            },
                            {
                                "ce:given-name": "Nitinan",
                                "preferred-name": {
                                    "ce:given-name": "Nitinan",
                                    "ce:initials": "N.",
                                    "ce:surname": "Kantachadvanich",
                                    "ce:indexed-name": "Kantachadvanich N."
                                },
                                "@seq": "6",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "RN",
                                "ce:surname": "Kantachadvanich",
                                "@auid": "57202059789",
                                "ce:indexed-name": "Kantachadvanich N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60026796",
                            "@country": "esp",
                            "city": "Madrid",
                            "organization": [
                                {"$": "Movement Disorders Unit"},
                                {"$": "Department of Neurology"},
                                {"$": "Fundacion Jimenez Diaz"},
                                {"$": "Universidad Autonoma de Madrid"}
                            ],
                            "affiliation-id": {
                                "@afid": "60026796",
                                "@dptid": "108058480"
                            },
                            "ce:source-text": "Movement Disorders Unit Department of Neurology Fundacion Jimenez Diaz Universidad Autonoma de Madrid Madrid Spain.",
                            "@dptid": "108058480"
                        },
                        "author": [{
                            "ce:given-name": "Pedro J.",
                            "preferred-name": {
                                "ce:given-name": "Pedro J.",
                                "ce:initials": "P.J.",
                                "ce:surname": "García Ruiz",
                                "ce:indexed-name": "García Ruiz P.J."
                            },
                            "@seq": "7",
                            "ce:initials": "P.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "García Ruiz",
                            "@auid": "57202572534",
                            "ce:indexed-name": "Garcia Ruiz P.J."
                        }]
                    }
                ],
                "citation-title": "Long-term Apomorphine Infusion Users Versus Short-term Users: An International Dual-center Analysis of the Reasons for Discontinuing Therapy",
                "abstracts": "© Wolters Kluwer Health, Inc. All rights reserved.Objectives A retrospective analysis at 2 specialist centers was undertaken to determine the long-term efficacy of subcutaneous apomorphine infusion (APO), rates and reasons for discontinuation, and factors that might contribute to discontinuation. Methods Demographics, clinical outcomes data, and reasons for discontinuation were collected for patients treated with APO at Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Bangkok, Thailand (n = 36) and Fundacion Jimemez Diaz Universidad Autonoma de Madrid, Spain (n = 16). Results There were 19 (52.7%) patients in the Thai cohort and 10 (62.5%) patients in the Spanish cohort who discontinued treatment within around 6 months of initiation, most commonly due to skin nodules (Thai cohort) and perceived lack of efficacy (Spanish cohort). Those who continued APO tended to stay on treatment. In both cohorts, APO resulted in significant reductions in Unified Parkinson's Disease Rating Scale 3 motor scores, daily OFF time, and levodopa-equivalent dose in patients who subsequently stopped therapy, suggesting APO is clinically effective even when \"lack of efficacy\" is stated as a reason for discontinuing. Daily OFF hours after APO therapy was found to be a significant predictive factor for APO discontinuation with an odds ratio of 5.952 (P = 0.040). The cutoff point that determined APO discontinuation was calculated to be 1.75 or more OFF hours (sensitivity, 84.6%; specificity, 63.2%). Conclusions Apomorphine infusion is a minimally invasive therapy and therefore very easy to discontinue if difficulties arise. This fact might explain the high dropout rate of this technique. Successful long-term adherence to APO therapy requires a multidisciplinary health care team approach including regular patient follow-up and assessment and prompt resolution of queries and concerns.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "address-part": "1873 Rama 4 Rd",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Pathumwan, Bangkok",
                        "organization": [
                            {"$": "Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders"},
                            {"$": "Chulalongkorn University Hospital"}
                        ],
                        "ce:source-text": "Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders Chulalongkorn University Hospital 1873 Rama 4 Rd, Pathumwan, Bangkok 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Roongroj",
                        "ce:initials": "R.",
                        "ce:degrees": "MD, FRCP",
                        "ce:surname": "Bhidayasiri",
                        "ce:indexed-name": "Bhidayasiri R."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "apomorphine infusion",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Parkinson's disease/parkinsonism",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "retention in treatment",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://journals.lww.com/clinicalneuropharm/pages/default.aspx",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Clinical Neuropharmacology",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "42",
                            "@issue": "5"
                        },
                        "pagerange": {
                            "@first": "172",
                            "@last": "178"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Clinical Neuropharmacology",
                    "publicationdate": {
                        "month": "09",
                        "year": "2019",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 September 2019"
                        },
                        "day": "01"
                    },
                    "codencode": "CLNED",
                    "sourcetitle-abbrev": "Clin. Neuropharmacol.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "1537162X",
                            "@type": "electronic"
                        },
                        {
                            "$": "03625664",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2019"},
                    "publisher": {
                        "publishername": "Lippincott Williams and Wilkins",
                        "ce:e-address": {
                            "$": "kathiest.clai@apta.org",
                            "@type": "email"
                        }
                    },
                    "@srcid": "20602"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": {
                                "classification-code": "99",
                                "classification-description": "General"
                            }
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "8",
                                    "classification-description": "Neurology and Neurosurgery"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "3004"},
                                {"$": "2728"},
                                {"$": "2736"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "PHAR"},
                                {"$": "MEDI"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "314-19-2"},
                                        {"$": "58-00-4"},
                                        {"$": "41035-30-7"}
                                    ],
                                    "chemical-name": "apomorphine"
                                },
                                {
                                    "cas-registry-number": "59-92-7",
                                    "chemical-name": "levodopa"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antiparkinson Agents"},
                                {"chemical-name": "Apomorphine"},
                                {"chemical-name": "Levodopa"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Process",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "18",
                    "@year": "2020",
                    "@timestamp": "BST 03:41:18",
                    "@month": "02"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "630585910",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "629466946",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2020015079",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "923341789",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200037450",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "31567642",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20200102304",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20200148691",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85072761516",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85072761516",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "629466946",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76307999",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1097/WNF.0000000000000361"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "44",
                "reference": [
                    {
                        "ref-fulltext": "Chapuis S, Ouchchane L, Metz O,. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord 2005; 20 (2): 224-230.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Impact of the motor complications of Parkinson's disease on the quality of life"},
                            "refd-itemidlist": {"itemid": {
                                "$": "14944364987",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "224",
                                    "@last": "230"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Chapuis",
                                    "ce:indexed-name": "Chapuis S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Ouchchane",
                                    "ce:indexed-name": "Ouchchane L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Metz",
                                    "ce:indexed-name": "Metz O."
                                }
                            ]},
                            "ref-sourcetitle": "Mov Disord"
                        },
                        "ce:source-text": "Chapuis S, Ouchchane L, Metz O,. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord 2005; 20 (2): 224-230."
                    },
                    {
                        "ref-fulltext": "Martinez-Martin P,. Nonmotor symptoms and health-related quality of life in early Parkinson's disease. Mov Disord 2014; 29 (2): 166-168.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Nonmotor symptoms and health-related quality of life in early Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84894231075",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "166",
                                    "@last": "168"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "ce:surname": "Martinez-Martin",
                                "ce:indexed-name": "Martinez-Martin P."
                            }]},
                            "ref-sourcetitle": "Mov Disord"
                        },
                        "ce:source-text": "Martinez-Martin P,. Nonmotor symptoms and health-related quality of life in early Parkinson's disease. Mov Disord 2014; 29 (2): 166-168."
                    },
                    {
                        "ref-fulltext": "Rahman S, Griffin HJ, Quinn NP,. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 2008; 23 (10): 1428-1434.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Quality of life in Parkinson's disease: The relative importance of the symptoms"},
                            "refd-itemidlist": {"itemid": {
                                "$": "52649147662",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1428",
                                    "@last": "1434"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Rahman",
                                    "ce:indexed-name": "Rahman S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Griffin",
                                    "ce:indexed-name": "Griffin H.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Quinn",
                                    "ce:indexed-name": "Quinn N.P."
                                }
                            ]},
                            "ref-sourcetitle": "Mov Disord"
                        },
                        "ce:source-text": "Rahman S, Griffin HJ, Quinn NP,. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 2008; 23 (10): 1428-1434."
                    },
                    {
                        "ref-fulltext": "Obeso JA, Grandas F, Vaamonde J,. Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy. Funct Neurol 1988; 3 (4): 413-427.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1988"},
                            "ref-title": {"ref-titletext": "Continuous dopaminergic stimulation for Parkinson's disease: Facts and fancy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0024148418",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "413",
                                    "@last": "427"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Obeso",
                                    "ce:indexed-name": "Obeso J.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Grandas",
                                    "ce:indexed-name": "Grandas F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Vaamonde",
                                    "ce:indexed-name": "Vaamonde J."
                                }
                            ]},
                            "ref-sourcetitle": "Funct Neurol"
                        },
                        "ce:source-text": "Obeso JA, Grandas F, Vaamonde J,. Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy. Funct Neurol 1988; 3 (4): 413-427."
                    },
                    {
                        "ref-fulltext": "Nutt JG, Obeso JA, Stocchi F,. Continuous dopamine-receptor stimulation in advanced Parkinson's disease. Trends Neurosci 2000; 23 (Suppl 10): S109-S115.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Continuous dopamine-receptor stimulation in advanced Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0033696872",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "S109",
                                    "@last": "S115"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Nutt",
                                    "ce:indexed-name": "Nutt J.G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Obeso",
                                    "ce:indexed-name": "Obeso J.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Stocchi",
                                    "ce:indexed-name": "Stocchi F."
                                }
                            ]},
                            "ref-sourcetitle": "Trends Neurosci"
                        },
                        "ce:source-text": "Nutt JG, Obeso JA, Stocchi F,. Continuous dopamine-receptor stimulation in advanced Parkinson's disease. Trends Neurosci 2000; 23 (Suppl 10): S109-S115."
                    },
                    {
                        "ref-fulltext": "Chaudhuri KR, Rizos A, Sethi KD,. Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery? J Neural Transm 2013; 120 (9): 1305-1320.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Motor and nonmotor complications in Parkinson's disease: An argument for continuous drug delivery?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84883455518",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "120",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1305",
                                    "@last": "1320"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Chaudhuri",
                                    "ce:indexed-name": "Chaudhuri K.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Rizos",
                                    "ce:indexed-name": "Rizos A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Sethi",
                                    "ce:indexed-name": "Sethi K.D."
                                }
                            ]},
                            "ref-sourcetitle": "J Neural Transm"
                        },
                        "ce:source-text": "Chaudhuri KR, Rizos A, Sethi KD,. Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery? J Neural Transm 2013; 120 (9): 1305-1320."
                    },
                    {
                        "ref-fulltext": "Jenner P, Katzenschlager R,. Apomorphine-pharmacological properties and clinical trials in Parkinson's disease. Parkinsonism Relat Disord 2016; 33 (Suppl 1): S13-S21.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Apomorphine - Pharmacological properties and clinical trials in Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85007477149",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "S13",
                                    "@last": "S21"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Jenner",
                                    "ce:indexed-name": "Jenner P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Katzenschlager",
                                    "ce:indexed-name": "Katzenschlager R."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Jenner P, Katzenschlager R,. Apomorphine-pharmacological properties and clinical trials in Parkinson's disease. Parkinsonism Relat Disord 2016; 33 (Suppl 1): S13-S21."
                    },
                    {
                        "ref-fulltext": "Trenkwalder C, Chaudhuri KR, Garcia Ruiz PJ,. Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease-clinical practice recommendations. Parkinsonism Relat Disord 2015; 21 (9): 1023-1030.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84940615116",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1023",
                                    "@last": "1030"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Trenkwalder",
                                    "ce:indexed-name": "Trenkwalder C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Chaudhuri",
                                    "ce:indexed-name": "Chaudhuri K.R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Garcia Ruiz",
                                    "ce:indexed-name": "Garcia Ruiz P.J."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Trenkwalder C, Chaudhuri KR, Garcia Ruiz PJ,. Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease-clinical practice recommendations. Parkinsonism Relat Disord 2015; 21 (9): 1023-1030."
                    },
                    {
                        "ref-fulltext": "Deuschl G, Schade-Brittinger C, Krack P,. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355 (9): 896-908.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "A randomized trial of deep-brain stimulation for Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33748139412",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "355",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "896",
                                    "@last": "908"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Deuschl",
                                    "ce:indexed-name": "Deuschl G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Schade-Brittinger",
                                    "ce:indexed-name": "Schade-Brittinger C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Krack",
                                    "ce:indexed-name": "Krack P."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Deuschl G, Schade-Brittinger C, Krack P,. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355 (9): 896-908."
                    },
                    {
                        "ref-fulltext": "Olanow CW, Kieburtz K, Odin P,. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 2014; 13 (2): 141-149.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: A randomised, controlled, double-blind, double-dummy study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892516916",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "141",
                                    "@last": "149"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Olanow",
                                    "ce:indexed-name": "Olanow C.W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Kieburtz",
                                    "ce:indexed-name": "Kieburtz K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Odin",
                                    "ce:indexed-name": "Odin P."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet Neurol"
                        },
                        "ce:source-text": "Olanow CW, Kieburtz K, Odin P,. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 2014; 13 (2): 141-149."
                    },
                    {
                        "ref-fulltext": "Odin P, Ray Chaudhuri K, Slevin JT,. Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: consensus from an international survey and discussion program. Parkinsonism Relat Disord 2015; 21 (10): 1133-1144.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84942191840",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1133",
                                    "@last": "1144"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Odin",
                                    "ce:indexed-name": "Odin P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Ray Chaudhuri",
                                    "ce:indexed-name": "Ray Chaudhuri K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Slevin",
                                    "ce:indexed-name": "Slevin J.T."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Odin P, Ray Chaudhuri K, Slevin JT,. Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: consensus from an international survey and discussion program. Parkinsonism Relat Disord 2015; 21 (10): 1133-1144."
                    },
                    {
                        "ref-fulltext": "APO-go PFS 5mg/ml Solution for Infusion in Pre-filled Syringe. EU Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/3908/smpc. Accessed 30 April 2019.",
                        "@id": "12",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.medicines.org.uk/emc/product/3908/smpc",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85077867685",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "EU Summary of Product Characteristics. Accessed 30 April 2019",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "APO-go PFS 5mg/ml Solution for Infusion in Pre-filled Syringe",
                                "ce:indexed-name": "APO-go PFS 5mg/ml Solution for Infusion in Pre-filled Syringe"
                            }}
                        },
                        "ce:source-text": "APO-go PFS 5mg/ml Solution for Infusion in Pre-filled Syringe. EU Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/3908/smpc. Accessed 30 April 2019."
                    },
                    {
                        "ref-fulltext": "Antonini A, Tolosa E,. Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management. Expert Rev Neurother 2009; 9 (6): 859-867.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: Selection criteria and patient management"},
                            "refd-itemidlist": {"itemid": {
                                "$": "67649962702",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "859",
                                    "@last": "867"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Antonini",
                                    "ce:indexed-name": "Antonini A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Tolosa",
                                    "ce:indexed-name": "Tolosa E."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Neurother"
                        },
                        "ce:source-text": "Antonini A, Tolosa E,. Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management. Expert Rev Neurother 2009; 9 (6): 859-867."
                    },
                    {
                        "ref-fulltext": "Antonini A, Odin P,. Pros and cons of apomorphine and l-dopa continuous infusion in advanced Parkinson's disease. Parkinsonism Relat Disord 2009; 15 (Suppl 4): S97-S100.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Pros and cons of apomorphine and l -dopa continuous infusion in advanced Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "73049100901",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "S97",
                                    "@last": "S100"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Antonini",
                                    "ce:indexed-name": "Antonini A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Odin",
                                    "ce:indexed-name": "Odin P."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Antonini A, Odin P,. Pros and cons of apomorphine and l-dopa continuous infusion in advanced Parkinson's disease. Parkinsonism Relat Disord 2009; 15 (Suppl 4): S97-S100."
                    },
                    {
                        "ref-fulltext": "Volkmann J, Albanese A, Antonini A,. Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review. J Neurol 2013; 260 (11): 2701-2714.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: An evidence-based review"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84885108687",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "260",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "2701",
                                    "@last": "2714"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Volkmann",
                                    "ce:indexed-name": "Volkmann J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Albanese",
                                    "ce:indexed-name": "Albanese A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Antonini",
                                    "ce:indexed-name": "Antonini A."
                                }
                            ]},
                            "ref-sourcetitle": "J Neurol"
                        },
                        "ce:source-text": "Volkmann J, Albanese A, Antonini A,. Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review. J Neurol 2013; 260 (11): 2701-2714."
                    },
                    {
                        "ref-fulltext": "Dafsari HS, Martinez-Martin P, Rizos A,. EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease. Mov Disord 2019; 34: 353-365.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061050019",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "353",
                                    "@last": "365"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Dafsari",
                                    "ce:indexed-name": "Dafsari H.S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Martinez-Martin",
                                    "ce:indexed-name": "Martinez-Martin P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Rizos",
                                    "ce:indexed-name": "Rizos A."
                                }
                            ]},
                            "ref-sourcetitle": "Mov Disord"
                        },
                        "ce:source-text": "Dafsari HS, Martinez-Martin P, Rizos A,. EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease. Mov Disord 2019; 34: 353-365."
                    },
                    {
                        "ref-fulltext": "Bhidayasiri R, Chaudhuri KR, LeWitt P,. Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses. Clin Neuropharmacol 2015; 38 (3): 89-103.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Effective delivery of apomorphine in the management of Parkinson disease: Practical considerations for clinicians and Parkinson nurses"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84930080810",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "89",
                                    "@last": "103"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhidayasiri",
                                    "ce:indexed-name": "Bhidayasiri R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Chaudhuri",
                                    "ce:indexed-name": "Chaudhuri K.R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Lewitt",
                                    "ce:indexed-name": "Lewitt P."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Neuropharmacol"
                        },
                        "ce:source-text": "Bhidayasiri R, Chaudhuri KR, LeWitt P,. Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses. Clin Neuropharmacol 2015; 38 (3): 89-103."
                    },
                    {
                        "ref-fulltext": "Katzenschlager R, Poewe W, Rascol O,. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol 2018; 17 (9): 749-759.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): A multicentre, double-blind, randomised, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85053829496",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "749",
                                    "@last": "759"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Katzenschlager",
                                    "ce:indexed-name": "Katzenschlager R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Poewe",
                                    "ce:indexed-name": "Poewe W."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Rascol",
                                    "ce:indexed-name": "Rascol O."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet Neurol"
                        },
                        "ce:source-text": "Katzenschlager R, Poewe W, Rascol O,. Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol 2018; 17 (9): 749-759."
                    },
                    {
                        "ref-fulltext": "Unti E, Ceravolo R, Bonuccelli U,. Apomorphine hydrochloride for the treatment of Parkinson's disease. Expert Rev Neurother 2015; 15 (7): 723-732.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Apomorphine hydrochloride for the treatment of Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84933517231",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "723",
                                    "@last": "732"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Unti",
                                    "ce:indexed-name": "Unti E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Ceravolo",
                                    "ce:indexed-name": "Ceravolo R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "U.",
                                    "@_fa": "true",
                                    "ce:surname": "Bonuccelli",
                                    "ce:indexed-name": "Bonuccelli U."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Neurother"
                        },
                        "ce:source-text": "Unti E, Ceravolo R, Bonuccelli U,. Apomorphine hydrochloride for the treatment of Parkinson's disease. Expert Rev Neurother 2015; 15 (7): 723-732."
                    },
                    {
                        "ref-fulltext": "Manson AJ, Turner K, Lees AJ,. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients. Mov Disord 2002; 17 (6): 1235-1241.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0036869028",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1235",
                                    "@last": "1241"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Manson",
                                    "ce:indexed-name": "Manson A.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Turner",
                                    "ce:indexed-name": "Turner K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Lees",
                                    "ce:indexed-name": "Lees A.J."
                                }
                            ]},
                            "ref-sourcetitle": "Mov Disord"
                        },
                        "ce:source-text": "Manson AJ, Turner K, Lees AJ,. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients. Mov Disord 2002; 17 (6): 1235-1241."
                    },
                    {
                        "ref-fulltext": "Borgemeester RW, Drent M, van Laar T,. Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients. Parkinsonism Relat Disord 2016; 23: 17-22.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84950123709",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "17",
                                    "@last": "22"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Borgemeester",
                                    "ce:indexed-name": "Borgemeester R.W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Drent",
                                    "ce:indexed-name": "Drent M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Laar",
                                    "ce:indexed-name": "Van Laar T."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Borgemeester RW, Drent M, van Laar T,. Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients. Parkinsonism Relat Disord 2016; 23: 17-22."
                    },
                    {
                        "ref-fulltext": "Borgemeester RWK, van Laar T,. Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: a retrospective long-term follow-up study. Parkinsonism Relat Disord 2017; 45: 33-38.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85030832825",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "33",
                                    "@last": "38"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.W.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Borgemeester",
                                    "ce:indexed-name": "Borgemeester R.W.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Laar",
                                    "ce:indexed-name": "Van Laar T."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Borgemeester RWK, van Laar T,. Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: a retrospective long-term follow-up study. Parkinsonism Relat Disord 2017; 45: 33-38."
                    },
                    {
                        "ref-fulltext": "Garcia Ruiz PJ, Sesar Ignacio A, Ares Pensado B,. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov Disord 2008; 23 (8): 1130-1136.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "52649108045",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1130",
                                    "@last": "1136"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Garcia Ruiz",
                                    "ce:indexed-name": "Garcia Ruiz P.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sesar Ignacio",
                                    "ce:indexed-name": "Sesar Ignacio A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Ares Pensado",
                                    "ce:indexed-name": "Ares Pensado B."
                                }
                            ]},
                            "ref-sourcetitle": "Mov Disord"
                        },
                        "ce:source-text": "Garcia Ruiz PJ, Sesar Ignacio A, Ares Pensado B,. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov Disord 2008; 23 (8): 1130-1136."
                    },
                    {
                        "ref-fulltext": "Pietz K, Hagell P, Odin P,. Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. J Neurol Neurosurg Psychiatry 1998; 65 (5): 709-716.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1998"},
                            "ref-title": {"ref-titletext": "Subcutaneous apomorphine in late stage Parkinson's disease: A long term follow up"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0031765885",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "709",
                                    "@last": "716"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Pietz",
                                    "ce:indexed-name": "Pietz K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Hagell",
                                    "ce:indexed-name": "Hagell P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Odin",
                                    "ce:indexed-name": "Odin P."
                                }
                            ]},
                            "ref-sourcetitle": "J Neurol Neurosurg Psychiatry"
                        },
                        "ce:source-text": "Pietz K, Hagell P, Odin P,. Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. J Neurol Neurosurg Psychiatry 1998; 65 (5): 709-716."
                    },
                    {
                        "ref-fulltext": "Sesar A, Fernandez-Pajarin G, Ares B,. Continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: 10-year experience with 230 patients. J Neurol 2017; 264 (5): 946-954.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: 10-year experience with 230 patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85016506036",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "264",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "946",
                                    "@last": "954"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sesar",
                                    "ce:indexed-name": "Sesar A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Fernandez-Pajarin",
                                    "ce:indexed-name": "Fernandez-Pajarin G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Ares",
                                    "ce:indexed-name": "Ares B."
                                }
                            ]},
                            "ref-sourcetitle": "J Neurol"
                        },
                        "ce:source-text": "Sesar A, Fernandez-Pajarin G, Ares B,. Continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: 10-year experience with 230 patients. J Neurol 2017; 264 (5): 946-954."
                    },
                    {
                        "ref-fulltext": "Wenning GK, Bösch S, Luginger E,. Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease. Adv Neurol 1999; 80: 545-548.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0032601891",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "80"},
                                "pagerange": {
                                    "@first": "545",
                                    "@last": "548"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Wenning",
                                    "ce:indexed-name": "Wenning G.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Bösch",
                                    "ce:indexed-name": "Bosch S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Luginger",
                                    "ce:indexed-name": "Luginger E."
                                }
                            ]},
                            "ref-sourcetitle": "Adv Neurol"
                        },
                        "ce:source-text": "Wenning GK, Bösch S, Luginger E,. Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease. Adv Neurol 1999; 80: 545-548."
                    },
                    {
                        "ref-fulltext": "Tyne HL, Parsons J, Sinnott A,. A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease. J Neurol 2004; 251 (11): 1370-1374.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "12744260002",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "251",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1370",
                                    "@last": "1374"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Tyne",
                                    "ce:indexed-name": "Tyne H.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Parsons",
                                    "ce:indexed-name": "Parsons J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sinnott",
                                    "ce:indexed-name": "Sinnott A."
                                }
                            ]},
                            "ref-sourcetitle": "J Neurol"
                        },
                        "ce:source-text": "Tyne HL, Parsons J, Sinnott A,. A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease. J Neurol 2004; 251 (11): 1370-1374."
                    },
                    {
                        "ref-fulltext": "Poewe W, Wenning GK,. Apomorphine: an underutilized therapy for Parkinson's disease. Mov Disord 2000; 15 (5): 789-794.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Apomorphine: An underutilized therapy for Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0033819538",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "789",
                                    "@last": "794"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Poewe",
                                    "ce:indexed-name": "Poewe W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Wenning",
                                    "ce:indexed-name": "Wenning G.K."
                                }
                            ]},
                            "ref-sourcetitle": "Mov Disord"
                        },
                        "ce:source-text": "Poewe W, Wenning GK,. Apomorphine: an underutilized therapy for Parkinson's disease. Mov Disord 2000; 15 (5): 789-794."
                    },
                    {
                        "ref-fulltext": "Kimber TE, Fang J, Huddy LJ,. Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study. Intern Med J 2017; 47 (5): 570-573.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Long-term adherence to apomorphine infusion in patients with Parkinson disease: A 10-year observational study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019219408",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "47",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "570",
                                    "@last": "573"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Kimber",
                                    "ce:indexed-name": "Kimber T.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Fang",
                                    "ce:indexed-name": "Fang J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Huddy",
                                    "ce:indexed-name": "Huddy L.J."
                                }
                            ]},
                            "ref-sourcetitle": "Intern Med J"
                        },
                        "ce:source-text": "Kimber TE, Fang J, Huddy LJ,. Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study. Intern Med J 2017; 47 (5): 570-573."
                    },
                    {
                        "ref-fulltext": "Bhidayasiri R, Boonpang K, Jitkritsadakul O,. Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy. Parkinsonism Relat Disord 2016; 33 (Suppl 1): S49-S55.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85007483192",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "S49",
                                    "@last": "S55"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhidayasiri",
                                    "ce:indexed-name": "Bhidayasiri R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Boonpang",
                                    "ce:indexed-name": "Boonpang K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Jitkritsadakul",
                                    "ce:indexed-name": "Jitkritsadakul O."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Bhidayasiri R, Boonpang K, Jitkritsadakul O,. Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy. Parkinsonism Relat Disord 2016; 33 (Suppl 1): S49-S55."
                    },
                    {
                        "ref-fulltext": "Jitkritsadakul O, Boonrod N, Bhidayasiri R,. Knowledge, attitudes and perceptions of Parkinson's disease: a cross-sectional survey of Asian patients. J Neurol Sci 2017; 374: 69-74.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Knowledge, attitudes and perceptions of Parkinson's disease: A cross-sectional survey of Asian patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85009814697",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "374"},
                                "pagerange": {
                                    "@first": "69",
                                    "@last": "74"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Jitkritsadakul",
                                    "ce:indexed-name": "Jitkritsadakul O."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Boonrod",
                                    "ce:indexed-name": "Boonrod N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhidayasiri",
                                    "ce:indexed-name": "Bhidayasiri R."
                                }
                            ]},
                            "ref-sourcetitle": "J Neurol Sci"
                        },
                        "ce:source-text": "Jitkritsadakul O, Boonrod N, Bhidayasiri R,. Knowledge, attitudes and perceptions of Parkinson's disease: a cross-sectional survey of Asian patients. J Neurol Sci 2017; 374: 69-74."
                    },
                    {
                        "ref-fulltext": "Davidson MB, McGhee DJ, Counsell CE,. Comparison of patient rated treatment response with measured improvement in Parkinson's disease. J Neurol Neurosurg Psychiatry 2012; 83 (10): 1001-1005.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Comparison of patient rated treatment response with measured improvement in Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84866180938",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "83",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1001",
                                    "@last": "1005"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Davidson",
                                    "ce:indexed-name": "Davidson M.B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.J.",
                                    "@_fa": "true",
                                    "ce:surname": "McGhee",
                                    "ce:indexed-name": "McGhee D.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Counsell",
                                    "ce:indexed-name": "Counsell C.E."
                                }
                            ]},
                            "ref-sourcetitle": "J Neurol Neurosurg Psychiatry"
                        },
                        "ce:source-text": "Davidson MB, McGhee DJ, Counsell CE,. Comparison of patient rated treatment response with measured improvement in Parkinson's disease. J Neurol Neurosurg Psychiatry 2012; 83 (10): 1001-1005."
                    },
                    {
                        "ref-fulltext": "Jinnah HA, Comella CL, Perlmutter J,. Longitudinal studies of botulinum toxin in cervical dystonia: why do patients discontinue therapy? Toxicon 2018; 147: 89-95.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85028862746",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "147"},
                                "pagerange": {
                                    "@first": "89",
                                    "@last": "95"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jinnah",
                                    "ce:indexed-name": "Jinnah H.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Comella",
                                    "ce:indexed-name": "Comella C.L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Perlmutter",
                                    "ce:indexed-name": "Perlmutter J."
                                }
                            ]},
                            "ref-sourcetitle": "Toxicon"
                        },
                        "ce:source-text": "Jinnah HA, Comella CL, Perlmutter J,. Longitudinal studies of botulinum toxin in cervical dystonia: why do patients discontinue therapy? Toxicon 2018; 147: 89-95."
                    },
                    {
                        "ref-fulltext": "Kröger E, van Marum R, Souverein P,. Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: a retrospective cohort study. Drugs Aging 2010; 27 (8): 663-675.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77954985141",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "663",
                                    "@last": "675"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Kröger",
                                    "ce:indexed-name": "Kroger E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Marum",
                                    "ce:indexed-name": "Van Marum R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Souverein",
                                    "ce:indexed-name": "Souverein P."
                                }
                            ]},
                            "ref-sourcetitle": "Drugs Aging"
                        },
                        "ce:source-text": "Kröger E, van Marum R, Souverein P,. Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: a retrospective cohort study. Drugs Aging 2010; 27 (8): 663-675."
                    },
                    {
                        "ref-fulltext": "Arbouw ME, Movig KL, Guchelaar HJ,. Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials. Eur J Clin Pharmacol 2008; 64 (10): 1021-1026.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: Clinical practice versus clinical trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "53249095555",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1021",
                                    "@last": "1026"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Arbouw",
                                    "ce:indexed-name": "Arbouw M.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Movig",
                                    "ce:indexed-name": "Movig K.L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Guchelaar",
                                    "ce:indexed-name": "Guchelaar H.J."
                                }
                            ]},
                            "ref-sourcetitle": "Eur J Clin Pharmacol"
                        },
                        "ce:source-text": "Arbouw ME, Movig KL, Guchelaar HJ,. Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials. Eur J Clin Pharmacol 2008; 64 (10): 1021-1026."
                    },
                    {
                        "ref-fulltext": "Regidor I, Santos-García D, Catalán MIJ,. Impact of disease duration in effectiveness of treatment with levodopa-carbidopa intestinal gel and factors leading to discontinuation. J Park Dis 2019; 9 (1): 173-182.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Impact of disease duration in effectiveness of treatment with levodopa-carbidopa intestinal gel and factors leading to discontinuation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061185780",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "173",
                                    "@last": "182"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Regidor",
                                    "ce:indexed-name": "Regidor I."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Santos-García",
                                    "ce:indexed-name": "Santos-Garcia D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.I.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Catalán",
                                    "ce:indexed-name": "Catalan M.I.J."
                                }
                            ]},
                            "ref-sourcetitle": "J Park Dis"
                        },
                        "ce:source-text": "Regidor I, Santos-García D, Catalán MIJ,. Impact of disease duration in effectiveness of treatment with levodopa-carbidopa intestinal gel and factors leading to discontinuation. J Park Dis 2019; 9 (1): 173-182."
                    },
                    {
                        "ref-fulltext": "Fernandez HH, Boyd JT, Fung VSC,. Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease. Mov Disord 2018; 33 (6): 928-936.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044295884",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "928",
                                    "@last": "936"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Fernandez",
                                    "ce:indexed-name": "Fernandez H.H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Boyd",
                                    "ce:indexed-name": "Boyd J.T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "V.S.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Fung",
                                    "ce:indexed-name": "Fung V.S.C."
                                }
                            ]},
                            "ref-sourcetitle": "Mov Disord"
                        },
                        "ce:source-text": "Fernandez HH, Boyd JT, Fung VSC,. Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease. Mov Disord 2018; 33 (6): 928-936."
                    },
                    {
                        "ref-fulltext": "Sensi M, Cossu G, Mancini F,. Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up. Parkinsonism Relat Disord 2017; 38: 90-92.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85013472275",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "90",
                                    "@last": "92"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Sensi",
                                    "ce:indexed-name": "Sensi M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Cossu",
                                    "ce:indexed-name": "Cossu G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Mancini",
                                    "ce:indexed-name": "Mancini F."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Sensi M, Cossu G, Mancini F,. Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up. Parkinsonism Relat Disord 2017; 38: 90-92."
                    },
                    {
                        "ref-fulltext": "Buongiorno M, Antonelli F, Camara A,. Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: the Barcelona registry. Parkinsonism Relat Disord 2015; 21 (8): 871-876.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84937512510",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "871",
                                    "@last": "876"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Buongiorno",
                                    "ce:indexed-name": "Buongiorno M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Antonelli",
                                    "ce:indexed-name": "Antonelli F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Camara",
                                    "ce:indexed-name": "Camara A."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Buongiorno M, Antonelli F, Camara A,. Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: the Barcelona registry. Parkinsonism Relat Disord 2015; 21 (8): 871-876."
                    },
                    {
                        "ref-fulltext": "Calandrella D, Romito LM, Elia AE,. Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease. Neurology 2015; 84 (16): 1669-1672.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84928128279",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "84",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "1669",
                                    "@last": "1672"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Calandrella",
                                    "ce:indexed-name": "Calandrella D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Romito",
                                    "ce:indexed-name": "Romito L.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Elia",
                                    "ce:indexed-name": "Elia A.E."
                                }
                            ]},
                            "ref-sourcetitle": "Neurology"
                        },
                        "ce:source-text": "Calandrella D, Romito LM, Elia AE,. Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease. Neurology 2015; 84 (16): 1669-1672."
                    },
                    {
                        "ref-fulltext": "Bhidayasiri R, Sringean J, Anan C,. Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors. Parkinsonism Relat Disord 2016; 33 (Suppl 1): S36-S41.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85007506771",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "S36",
                                    "@last": "S41"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhidayasiri",
                                    "ce:indexed-name": "Bhidayasiri R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Sringean",
                                    "ce:indexed-name": "Sringean J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Anan",
                                    "ce:indexed-name": "Anan C."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Bhidayasiri R, Sringean J, Anan C,. Quantitative demonstration of the efficacy of night-time apomorphine infusion to treat nocturnal hypokinesia in Parkinson's disease using wearable sensors. Parkinsonism Relat Disord 2016; 33 (Suppl 1): S36-S41."
                    },
                    {
                        "ref-fulltext": "Bhidayasiri R, Sringean J, Thanawattano C,. Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson's disease: an evidence-based review. Parkinsonism Relat Disord 2016; 22 (Suppl 1): S127-S133.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson's disease: An evidence-based review"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84947785615",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "S127",
                                    "@last": "S133"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhidayasiri",
                                    "ce:indexed-name": "Bhidayasiri R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Sringean",
                                    "ce:indexed-name": "Sringean J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Thanawattano",
                                    "ce:indexed-name": "Thanawattano C."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Bhidayasiri R, Sringean J, Thanawattano C,. Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson's disease: an evidence-based review. Parkinsonism Relat Disord 2016; 22 (Suppl 1): S127-S133."
                    },
                    {
                        "ref-fulltext": "Bhidayasiri R, Trenkwalder C,. Getting a good night sleep? The importance of recognizing and treating nocturnal hypokinesia in Parkinson's disease. Parkinsonism Relat Disord 2018; 50: 10-18.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Getting a good night sleep? the importance of recognizing and treating nocturnal hypokinesia in Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85040335469",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "50"},
                                "pagerange": {
                                    "@first": "10",
                                    "@last": "18"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Bhidayasiri",
                                    "ce:indexed-name": "Bhidayasiri R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Trenkwalder",
                                    "ce:indexed-name": "Trenkwalder C."
                                }
                            ]},
                            "ref-sourcetitle": "Parkinsonism Relat Disord"
                        },
                        "ce:source-text": "Bhidayasiri R, Trenkwalder C,. Getting a good night sleep? The importance of recognizing and treating nocturnal hypokinesia in Parkinson's disease. Parkinsonism Relat Disord 2018; 50: 10-18."
                    },
                    {
                        "ref-fulltext": "Sringean J, Anan C, Thanawattano C,. Time for a strategy in night-time dopaminergic therapy? An objective sensor-based analysis of nocturnal hypokinesia and sleeping positions in Parkinson's disease. J Neurol Sci 2017; 373: 244-248.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Time for a strategy in night-time dopaminergic therapy? An objective sensor-based analysis of nocturnal hypokinesia and sleeping positions in Parkinson's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85008692987",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "373"},
                                "pagerange": {
                                    "@first": "244",
                                    "@last": "248"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Sringean",
                                    "ce:indexed-name": "Sringean J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Anan",
                                    "ce:indexed-name": "Anan C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Thanawattano",
                                    "ce:indexed-name": "Thanawattano C."
                                }
                            ]},
                            "ref-sourcetitle": "J Neurol Sci"
                        },
                        "ce:source-text": "Sringean J, Anan C, Thanawattano C,. Time for a strategy in night-time dopaminergic therapy? An objective sensor-based analysis of nocturnal hypokinesia and sleeping positions in Parkinson's disease. J Neurol Sci 2017; 373: 244-248."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Madrid",
            "@id": "60026796",
            "affilname": "Universidad Autónoma de Madrid",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026796",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85072761516",
        "dc:description": "Objectives A retrospective analysis at 2 specialist centers was undertaken to determine the long-term efficacy of subcutaneous apomorphine infusion (APO), rates and reasons for discontinuation, and factors that might contribute to discontinuation. Methods Demographics, clinical outcomes data, and reasons for discontinuation were collected for patients treated with APO at Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Bangkok, Thailand (n = 36) and Fundacion Jimemez Diaz Universidad Autonoma de Madrid, Spain (n = 16). Results There were 19 (52.7%) patients in the Thai cohort and 10 (62.5%) patients in the Spanish cohort who discontinued treatment within around 6 months of initiation, most commonly due to skin nodules (Thai cohort) and perceived lack of efficacy (Spanish cohort). Those who continued APO tended to stay on treatment. In both cohorts, APO resulted in significant reductions in Unified Parkinson's Disease Rating Scale 3 motor scores, daily OFF time, and levodopa-equivalent dose in patients who subsequently stopped therapy, suggesting APO is clinically effective even when \"lack of efficacy\" is stated as a reason for discontinuing. Daily OFF hours after APO therapy was found to be a significant predictive factor for APO discontinuation with an odds ratio of 5.952 (P = 0.040). The cutoff point that determined APO discontinuation was calculated to be 1.75 or more OFF hours (sensitivity, 84.6%; specificity, 63.2%). Conclusions Apomorphine infusion is a minimally invasive therapy and therefore very easy to discontinue if difficulties arise. This fact might explain the high dropout rate of this technique. Successful long-term adherence to APO therapy requires a multidisciplinary health care team approach including regular patient follow-up and assessment and prompt resolution of queries and concerns.",
        "pubmed-id": "31567642",
        "prism:coverDate": "2019-09-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85072761516",
        "dc:creator": {"author": [{
            "ce:given-name": "Roongroj",
            "preferred-name": {
                "ce:given-name": "Roongroj",
                "ce:initials": "R.",
                "ce:surname": "Bhidayasiri",
                "ce:indexed-name": "Bhidayasiri R."
            },
            "@seq": "1",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "MD, FRCP",
            "ce:surname": "Bhidayasiri",
            "@auid": "55882458500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55882458500",
            "ce:indexed-name": "Bhidayasiri R."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85072761516"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072761516&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85072761516&origin=inward"
            }
        ],
        "source-id": "20602",
        "citedby-count": "10",
        "prism:volume": "42",
        "subtype": "ar",
        "dc:title": "Long-term Apomorphine Infusion Users Versus Short-term Users: An International Dual-center Analysis of the Reasons for Discontinuing Therapy",
        "openaccess": "0",
        "prism:issn": "1537162X 03625664",
        "publishercopyright": "© Wolters Kluwer Health, Inc. All rights reserved.",
        "prism:issueIdentifier": "5",
        "subtypeDescription": "Article",
        "prism:publicationName": "Clinical Neuropharmacology",
        "prism:pageRange": "172-178",
        "prism:endingPage": "178",
        "openaccessFlag": "false",
        "prism:doi": "10.1097/WNF.0000000000000361",
        "prism:startingPage": "172",
        "dc:identifier": "SCOPUS_ID:85072761516",
        "dc:publisher": "Lippincott Williams and Wilkinskathiest.clai@apta.org"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antiparkinson Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Apomorphine",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Cohort Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Infusions, Subcutaneous",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Levodopa",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Parkinson Disease",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Retrospective Studies",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "apomorphine infusion"
        },
        {
            "@_fa": "true",
            "$": "Parkinson's disease/parkinsonism"
        },
        {
            "@_fa": "true",
            "$": "retention in treatment"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Roongroj",
            "preferred-name": {
                "ce:given-name": "Roongroj",
                "ce:initials": "R.",
                "ce:surname": "Bhidayasiri",
                "ce:indexed-name": "Bhidayasiri R."
            },
            "@seq": "1",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "MD, FRCP",
            "ce:surname": "Bhidayasiri",
            "@auid": "55882458500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55882458500",
            "ce:indexed-name": "Bhidayasiri R."
        },
        {
            "ce:given-name": "Onanong",
            "preferred-name": {
                "ce:given-name": "Onanong",
                "ce:initials": "O.",
                "ce:surname": "Phokaewvarangkul",
                "ce:indexed-name": "Phokaewvarangkul O."
            },
            "@seq": "2",
            "ce:initials": "O.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Phokaewvarangkul",
            "@auid": "57204085936",
            "author-url": "https://api.elsevier.com/content/author/author_id/57204085936",
            "ce:indexed-name": "Phokaewvarangkul O."
        },
        {
            "ce:given-name": "Kamolwan",
            "preferred-name": {
                "ce:given-name": "Kamolwan",
                "ce:initials": "K.",
                "ce:surname": "Boonpang",
                "ce:indexed-name": "Boonpang K."
            },
            "@seq": "3",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "RN",
            "ce:surname": "Boonpang",
            "@auid": "56660632600",
            "author-url": "https://api.elsevier.com/content/author/author_id/56660632600",
            "ce:indexed-name": "Boonpang K."
        },
        {
            "ce:given-name": "Thanatat",
            "preferred-name": {
                "ce:given-name": "Thanatat",
                "ce:initials": "T.",
                "ce:surname": "Boonmongkol",
                "ce:indexed-name": "Boonmongkol T."
            },
            "@seq": "4",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "MD",
            "ce:surname": "Boonmongkol",
            "@auid": "57211136260",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211136260",
            "ce:indexed-name": "Boonmongkol T."
        },
        {
            "ce:given-name": "Yuwadee",
            "preferred-name": {
                "ce:given-name": "Yuwadee",
                "ce:initials": "Y.",
                "ce:surname": "Thongchuem",
                "ce:indexed-name": "Thongchuem Y."
            },
            "@seq": "5",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "MD",
            "ce:surname": "Thongchuem",
            "@auid": "57211142161",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211142161",
            "ce:indexed-name": "Thongchuem Y."
        },
        {
            "ce:given-name": "Nitinan",
            "preferred-name": {
                "ce:given-name": "Nitinan",
                "ce:initials": "N.",
                "ce:surname": "Kantachadvanich",
                "ce:indexed-name": "Kantachadvanich N."
            },
            "@seq": "6",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "RN",
            "ce:surname": "Kantachadvanich",
            "@auid": "57202059789",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202059789",
            "ce:indexed-name": "Kantachadvanich N."
        },
        {
            "ce:given-name": "Pedro J.",
            "preferred-name": {
                "ce:given-name": "Pedro J.",
                "ce:initials": "P.J.",
                "ce:surname": "García Ruiz",
                "ce:indexed-name": "García Ruiz P.J."
            },
            "@seq": "7",
            "ce:initials": "P.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026796",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026796"
            },
            "ce:degrees": "MD",
            "ce:surname": "García Ruiz",
            "@auid": "57202572534",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202572534",
            "ce:indexed-name": "Garcia Ruiz P.J."
        }
    ]}
}}